Inmune Bio (INMB) Invested Capital (2021 - 2024)
Inmune Bio's Invested Capital came in at $43.67 million for Q3 2024, down 22.4% from $56.31 million a year earlier and down 5.6% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Invested Capital (2021 - 2024) Analysis & Trends
For FY2023, Inmune Bio's Invested Capital was $47.26 million, down 36.8% from FY2022.
- Going back by year, Invested Capital was $74.8 million in FY2022 (-21.0%) and $94.68 million in FY2021.
- The five-year range for quarterly Invested Capital is $43.18 million (Q1 2024) to $102.66 million (Q3 2021).
- Year-over-year, Invested Capital has declined for nine consecutive quarters, with an average decline of 27.6% over the last eight quarters.
- The fastest year-over-year change in Invested Capital over five years came in Q2 2022 (growth of 46.8%), and the weakest in Q1 2024 (a decline of 38.4%).
- Business Quant data shows INMB's Invested Capital at $46.26 million (Q2 2024), $43.18 million (Q1 2024) and $47.26 million (Q4 2023) in the three quarters before Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Inmune Bio | 53.37 Mn | -38.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 43.67 Mn |
| Jun 30, 2024 | 46.26 Mn |
| Mar 31, 2024 | 43.18 Mn |
| Dec 31, 2023 | 47.26 Mn |
| Sep 30, 2023 | 56.31 Mn |
| Jun 30, 2023 | 65.48 Mn |
| Mar 31, 2023 | 70.06 Mn |
| Dec 31, 2022 | 74.80 Mn |
| Sep 30, 2022 | 78.34 Mn |
| Jun 30, 2022 | 84.50 Mn |
| Mar 31, 2022 | 90.16 Mn |
| Dec 31, 2021 | 94.68 Mn |
| Sep 30, 2021 | 102.66 Mn |
| Jun 30, 2021 | 57.58 Mn |
API Access
Inmune Bio Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();